Pharmacy on Web

wintersales_clearance

Your Shopping Cart




Your Cart is currently empty.

   

You are here: Home Pharmacy News Cardiac safety concerns with Antipsychotics
Decrease font size  Default font size  Increase font size 
Cardiac safety concerns with Antipsychotics

15 February 2010

Most of the currently available antipsychotics in use in NZ, have the side effects of QT interval prolongation, so patient have a risk of sudden cardiac death. Some popular antipsychotics includes:
Clozapine
Chlorpromazine
Haloperidol
Ziprasidone

Clinicians are recommended to avoid these in patients with clinically significant cardiac disorders and a history of ventricular arrhythmia or family history. Close monitoring with ECG is necessary for patients with increase risk factors.

 

 
Subscribe our Newsletter and receive the latest news and great deals.




SSL